Cytolytic bradykinin antagonists

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Bradykinin; kallidin; related peptides

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 9918

Patent

active

058498630

ABSTRACT:
The present invention provides bradykinin antagonists effective to inhibit cancer cell growth. Also provided are methods of inhibiting lung cancer cell growth by administering a therapeutically effective amount of a dimerized bradykinin antagonist.

REFERENCES:
patent: 4693993 (1987-09-01), Stewart et al.
patent: 5648336 (1997-07-01), Stewart et al.
patent: 5700779 (1997-12-01), Goodfellow et al.
Bunn, P. A., "Neuropeptide Signal Transduction in Lung Cancer: Clinical Implications of Bradykinin Sensitivity and Overall Heterogeneity," Cancer Res., 52, 24-31 (1992).
Bunn, P. A., et al., "Effects of Neuropeptide Analogues on Calcium Flux and Proliferation in Lung Cancer Cell Lines," Cancer Res., 54, 3602-3610 (1994).
Bunn, P. A., et al., "Neuropeptide Stimulation of Calcium Flux in Human Lung Cancer Cells: Delineation of Alternative Pathways," Proc. Natl. Acad. Sci. USA, 87, 2162-2166 (1990).
Cheronis, J. C., et al., "A New Class of Bradykinin Antagonists: Synthesis and In Vitro Activity of Bissuccinimidoalkane Peptide Dimers," J. Med. Chem., 35, 1563-1572 (1992).
Stewart, J. M., et al., "Bradykinin Chemistry: Agonists and Antagonists," In:Adv. Exp. Med. Biol., vol. 156, Fritz, H., (ed.), Plenum Press, New York, pp.585-589 (1983).
Vavrek, R. J., et al., "Succinyl Bis-Bradylinins: Potent Agonists with Exceptional Resistance to Enzymatic Degradation," In: Peptides--Structure and Function, Hruby, V. J., et al., (eds.), Pierce Chemical Company, Rockford, IL, pp.381-384 (1983).
Hawleys Condensed Chemical Dictionary, p. 1098 12th Edition (1993) "Suberic Acid".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cytolytic bradykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytolytic bradykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytolytic bradykinin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1459009

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.